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INTRODUCTION
46
Bacterial biofilm formation on prosthetic medical devices such as contact lenses, 47 indwelling catheters and artificial joints is a common cause of serious infections (8, 9, 48 12, 22, 32) . The formation of biofilms in these clinical settings has prompted interest in 49 developing inhibitors that are compatible with use on human tissues. We have 50 previously reported that polysorbate 80 (PS80), a non-ionic detergent and surfactant, 51 inhibits biofilm formation of the pathogen Pseudomonas aeruginosa and many other 52 bacteria at concentrations as low as 0.001% (39). Since PS80 is well tolerated on 53 human tissues at concentrations of 1% or more, this is a clinically relevant finding (17).
54
While the mechanism of action by which PS80 inhibits biofilm formation has not yet 55 been elucidated, PS80's ability to inhibit bacterial biofilm formation has been noted in 56 other independent publications (1, 13, 26).
57
Some clinical isolates of P. aeruginosa are resistant to PS80 biofilm inhibition, 58 prompting us to investigate the basis of this resistance in order to determine if PS80 59 formulations can be enhanced or modified to increase their spectrum of activity. As we 60 have reported, one mechanism of PS80 resistance by some strains of P. aeruginosa is 61 overexpression of a secreted lipase, LipA, resulting in cleavage of PS80 at its ester 62 bond. Based on these findings we identified a compound related to PS80, 63 polyethoxylated(20) oleyl alcohol, containing a lipase-resistant ether bond rather than 64 an ester bond. This compound was able to inhibit biofilm formation in LipA over-4 observed only in approximately 20% of the clinical isolates that exhibited resistance to 67 PS80. Responses to PS80 also vary among different P. aeruginosa laboratory strains.
68
Biofilm formation of P. aeruginosa PA14 (PA14) is inhibited in the presence of PS80, 69 while P. aeruginosa PAO1 (PAO1) forms robust biofilms under these conditions.
70
Similar to most clinical isolates we have investigated, lipase over production (and PS80 71 cleavage) is not the basis of the resistance to PS80 exhibited by PAO1.
72
To better understand non-lipase-dependent mechanisms of PS80 resistance in P. 73 aeruginosa, we performed a transposon mutagenesis of a clinical isolate, PA738, which 74 is resistant to PS80 mediated biofilm inhibition, but does not over produce lipase. Based 75 on this screen we found that the genes within the polysaccharide synthesis locus, psl, 76 play important roles in resistance to PS80 in PA738, PAO1 and other clinical P. 
MATERIALS AND METHODS
90
Bacterial strains and media 91 All P. aeruginosa strains used in this study are derived from P. aeruginosa PA14 (31) or 92 PAO1 (14) unless otherwise specified (see list of strains in Table 1 cultures for the assays were incubated for 24 h at 37˚C in M63 medium with 0.4% 108 arginine and 1mM MgSO 4 (M63) unless otherwise specified. Antibiotics were 6 E. coli, carbenicillin (Cb) was used at 500 µg/ml for P. aeruginosa, gentamicin (Gm) was 111 used at 10 µg/ml for E. coli and 50 µg/ml for P. aeruginosa, and nalidixic acid (Nx) was 112 used at 20 µg/ml.
113
Polysorbate 80 (PS80, Spectrum Chemicals, Gardena, California) was prepared as a 114 10% solution in MilliQ ultrapure water and used at the concentration of 0.1%, unless 115 otherwise noted.
116
Biofilm assays
117
Biofilm assays in 96-well PVC or polystyrene microtiter plates with crystal violet staining 118 of biofilms were performed as previously described (25, 27) . All biofilm cultures for the 119 assays were incubated for 24 h at 37˚C in M63 medium with 0.4% arginine and 1mM
120
MgSO 4 (M63) unless otherwise specified (28). The amount of biofilm present in each containing medium compared to the control that was grown in a medium lacking PS80.
127
Psl Dot blot assay
128
Crude exopolysaccharide extracts and dot blots to demonstrate the presence of Psl 129 production in PAO1 were performed as previously described (2). 
209
We used the Mariner transposon to perform a mutagenesis of PA738 in order to isolate 210 mutants which were unable to form biofilms when grown in the presence of PS80. We with a Mariner transposon inserted in a gene that shares high sequence identity to PA5322, the algC gene in PAO1. Therefore we concluded that our transposon had 217 disrupted the algC homolog of strain PA738 and will be referred to as algC hereafter. To 218 ensure that mutation of algC rather than an unknown mutation elsewhere in the 219 chromosome was responsible for the observed PS80 susceptible phenotype, we tested 220 strains with independent algC mutations in PAO1 (listed in Table 1 ). These previously 
228
We considered the possibility that the mutation of algC could result in reduced growth in indication that Psl might be related to PS80 resistance (34).
14
In support of this model, a PAO1 strain containing a deletion of the psl promoter 280 (WFPA800) ( Table 1 ) was unable to form biofilms in the presence of PS80 ( Figure 3A) 281 (2). Moreover, mutations of individual psl genes previously shown to be required for Psl 282 synthesis (14) also resulted in PS80-mediated sensitivity (Fig. 3A) . Similar results with 283 WFPA800 were found with biofilms formed both on polyvinyl chloride (PVC) or 284 polystyrene and in different culture media, LB and M63, indicating that these effects 285 were not surface or culture medium-dependent (data not shown). PA738 and PA715, 286 both PS80-resistant clinical isolates, were also rendered PS80 sensitive by a deletion of 287 the psl promoter (Table 1 and Figure 3B ). It is important to note that we evaluated 288 biofilms at 24 hours at which time we observed diminished but not the absence of 289 biofilms in strains with disrupted Psl production. This has been reported even in strains 290 with little or no biofilm formation at earlier time points in the absence of Psl (4).
291
We considered the possibility that disruption of Psl production in PAO1 and other strains 292 might broadly alter growth in PS80-containing media. If this were the case, apparent 293 sensitivity to PS80-mediated biofilm inhibition might simply reflect impaired growth.
294
However, planktonic growth of strain WFPA800 was in fact slightly enhanced in LB 295 containing 0.1% PS80 compared to LB alone suggesting that loss of Psl specifically 296 affects PAO1 ability to form biofilms in PS80 ( Figure 3C ). Similar results were obtained 297 when WFPA800 was cultured in M63 medium (data not shown).
298
PAO1 strains containing individual deletions of genes in the psl operon were tested for 299 biofilm formation in the presence and absence of PS80, respectively. Consistent with 300 the hypothesis that Psl is involved in PS80 resistance, disruption all 11 genes known to 301 be essential for Psl synthesis, pslACDEFGHIJKL (Table 1) formation or EPS over production but rather is specifically associated with Psl.
336
In strains known to produce both Psl and Pel, ZK2870 and MJK8, loss of Psl but 337 not Pel restores PS80 mediated biofilm inhibition 338 Since Psl in strains such as PAO1 is known to be important for biofilm formation, we 339 hypothesize that loss of Psl might render the bacteria susceptible to PS80 because of 340 an overall reduction in their facility to form biofilms rather than the loss of a specific 341 mechanism of resistance to PS80. To address this hypothesis, we investigated P. (Table 1) . Disruption of Psl production was accomplished in ZK2870 345 by deletion of the psl promoter, whereas in MJK8 a deletion of the pslBCDE was tested.
346
ZK2870 and MJK8 derivatives lacking both Psl and Pel were also evaluated. (Table 1) . Semiquantitative RT-PCR for pslA and rplU (as a positive control 361 for the RT-PCR) was performed to demonstrate presence or absence of expression 362 from the psl operon. As expected, rplU expression was observed in all strains, whereas 363 pslA expression was only observed in PAO1 and PA14 pMO0113050 (Figure 7 ).
364
PA14 pMO0113050 was able to form biofilms in 0.05% PS80 while wild-type PA14 or 365 PA14 pLAFR3 (vector control), did not (Figure 7) . These results did not appear to be 366 surface or culture medium-dependent since similar results were obtained when the 367 experiments were conducted when the cultures were grown on 96-well polystyrene plates using LB medium (data not shown). Additionally, we noted that biofilm formation 369 in the absence of PS80 was enhanced in PA14.
370
When we increased the PS80 concentration from 0.05% to 0.1%, PA14 pMO0113050 371 did not reproducibly form biofilms (data not shown). We speculate that this difference in 372 the therapeutic window of PS80 in PA14 pMO0113050 compared to wild-type PAO1 373 may reflect different levels of Psl production. Alternatively, there may be differential 374 expression of co-factors that interact with Psl and impact is ability to mediate PS80 375 resistance. However, since wild-type PA14 was inhibited at both concentrations of 376 PS80, these data strongly support the hypothesis that Psl production in P. aeruginosa 377 promotes biofilm formation in PS80.
378
DISCUSSION
379
Our data indicate that Psl production promotes biofilm formation of P. aeruginosa in Psl alters PS80 ability to function as a surfactant and thus reduce surface tension. All 420 these possibilities will be important avenues to explore in future investigations.
421
Interaction between PS80 and Psl in vitro may mirror more complex interactions 422 between bacteria and the many surfactants produced by microbes in the environment. A. Enzyme names represented in black indicates genes for which PAO1 deletion mutants were found be unable to form biofilms in PS80. Grey indicates strains in which deletion of the gene for the corresponding enzymes were able to form biofilms in PS80. Some enzymes involved in these biosynthetic pathways have been omitted from this figure, because their deletion mutants were not tested. B. Quantification of crystal violet staining associated with a representative 24-h biofilm assay of PA14 and PAO1 as controls and PAO1 strains containing transposon inserstions or deletions in PA14 and PAO1 as controls and PAO1 strains containing transposon inserstions or deletions in genes algC, rmlC, galU, wbpW, algD and rhlC. Black column = M63, Grey Column= M63 + 0.1% PS80. Paired histograms have a P-value less than 0.05, but * indicates when P>0.05. Each histogram is the mean of four replicates, and error bars indicate standard deviation. Quantification of 24h biofilm formation and representative images of biofilm wells in PA14, PAO1, WFPA800 (PAO1 with a deletion in the psl promoter) and WFPA801 (PAO1 with an arabinose inducible psl promoter). Black column = M63, Grey Column= M63 + 0.1% PS80. Percent arabinose is indicated below wells. Dot blots of polysaccharide extracts from PAO1, WFPA800, and WFPA801 grown with the noted arabinose concentrations on nitrocellulose, probed with anti-Psl polysaccharide antibodies and detected by nitrocellulose, probed with anti Psl polysaccharide antibodies and detected by chemiluminescence using a HRP-conjugated secondary antibody are shown beneath the corresponding biofilm wells. Paired histograms have a P-value less than 0.05, but * indicates when P>0.05. Each histogram is the mean of four replicates, and error bars indicate standard deviation. Quantification of crystal violet staining associated with 24h biofilm formation and representative well images of PAO1, PA14, pLAFR3 (PA14 containing the empty cosmid) and pMO0113050 (PA14 containing cosmid with psl operon) Underneath each well is RT PCR for pslA and rplU (as a control) to operon). Underneath each well is RT PCR for pslA and rplU (as a control) to demonstrate presence or absence of expression from the psl operon. Black column = M63, Grey Column= M63 + 0.1% PS80. Paired histograms have a P-value less than 0.05, but * indicates when P>0.05. Each histogram is the mean of four replicates, and error bars indicate standard deviation.
